Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Intelligent control system based on smart textiles to reduce pressure injury risk by real time measure of tissue viability, and intelligent trigger of prevention strategies adapted to user and context

Descrizione del progetto

Una tecnologia innovativa potrebbe contribuire a prevenire le lesioni da pressione a seguito di una lesione al midollo spinale

Nell’UE più di 200 000 pazienti convivono con una lesione al midollo spinale il cui impatto sulla qualità della vita di un individuo è elevato e i costi sociali sono enormi. Inoltre, la maggior parte di queste persone corre il rischio di sviluppare lesioni da pressione. Il progetto LiveRest, finanziato dall’UE, sta sviluppando una tecnologia assistiva che potrebbe contribuire a prevenire tale complicazione. La rivoluzionaria soluzione TIC sarà incorporata in una sedia a rotelle personalizzata, misurando il rischio di lesioni da pressione in tempo reale attraverso sensori di impedenza, pressione, temperatura e umidità. A seconda del livello di rischio e dell’utente, si ricorrerà a diversi interventi. La tecnologia prevista potrebbe aiutare il sistema sanitario pubblico europeo a risparmiare più di 40 milioni di euro all’anno sui trattamenti.

Obiettivo

85% of Spinal Cord Injury (SCI) patients will develop a Pressure Injury (PI), and 8% of them will die due to associated complications. PI treatment costs €20 billion per year to the European Public Health System (EPHS), uses a lot of resources (e.g. caregivers and hospital beds) and causes injuries to the caregivers that perform repositioning of the patients, resulting in compensation costs and extra human resource reduction. PI are preventable, however 38% of PI appear using current commercial prevention devices because PI risk assessment is only based on pressure instead of Tissue Viability (TV) which also takes into account user status and context. The aim of this project is to demonstrate in operational environment, produce and commercialise in the Assistive Technology market LiveRest system, a disruptive ICT solution that is able to avoid the development of PI, being the only device on the market that clinically demonstrates PI prevention. LiveRest will be embedded on a personalised wheelchair, and its novelties are: a) to measure PI risk in real time based on TV with impedance, pressure, temperature and humidity textile sensors; b) to decide the best combination of PI prevention strategies based on risk, user and context; and c) to perform the selected strategy based on combined actuation systems. LiveRest is aligned with key EU global challenges: disability, independent living, job inclusion, reduction of social and health care costs, and increase of labour. Target customers are SCI patients and hospitals. Benefits for the patients are increased sitting time and enhanced health, social inclusion, independent living and ageing well. EPHS savings will result in more than €40 million per year, plus avoid loss of medical resources. During Phase 2, we will achieve the free marketability of LiveRest, demonstrate the system in operational environment and elaborate an investor-ready business plan, including commercialisation and mass-production strategies.

Invito a presentare proposte

H2020-EIC-SMEInst-2018-2020

Vedi altri progetti per questo bando

Bando secondario

H2020-SMEInst-2018-2020-2

Meccanismo di finanziamento

SME-2 - SME instrument phase 2

Coordinatore

QIMOVA AS
Contribution nette de l'UE
€ 1 411 582,38
Indirizzo
LILLE HAVDRUPVEJ 5 GI HAVDRUP
4622 Havdrup
Danimarca

Mostra sulla mappa

PMI

L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.

Regione
Danmark Sjælland Østsjælland
Tipo di attività
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Collegamenti
Costo totale
€ 2 016 546,25